Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 3
1(50.0%)
2Total
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT05581368Recruiting

Studying the Effects of Cannabis on Vasculature

Role: collaborator

NCT05772442Not Yet Recruiting

Cardiac Transplant Metabolomics With and Without Rejection

Role: collaborator

NCT03221777Completed

Atrial Fibrillation Occurring Transiently With Stress (AFOTS)

Role: collaborator

NCT02590601Phase 3Withdrawn

Bromocriptine in the Treatment of Peripartum Cardiomyopathy

Role: collaborator

NCT03541616Completed

Prevalence of Subclinical Atrial Fibrillation in Heart Failure Patients and Its Relationship With Hospital Readmission

Role: collaborator

NCT03186976Not ApplicableCompleted

Reversal of Atrial Substrate to Prevent Atrial Fibrillation Pilot Study

Role: collaborator

NCT03234101Unknown

Meta-Analyses of Low-risk Lifestyle Behaviours and Patient Important Outcomes

Role: collaborator

All 7 trials loaded